Oncology Better balance of cancer treatment efficacy and toxicity The FDA Oncology Center of Excellence announced its Project Optimus draft guidance in January.
Oncology Optimised cancer drug dosing - FDA guidelines’ quantum leap Dose optimisation guidance for clinical trials was released by the FDA this January.
R&D Precision, speed, impact: Evolving mass spectrometry for med... MOBILion's Melissa Sherman explores the evolving role of mass spectrometry in drug discovery, complex molecule analysis, and medical research.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
